The severity of PPP2R5D-mutation-related ID along with the association of PP2A dysfunction with Alzheimer’s disease [8], Parkinson’s-like symptoms [9,10], and cancer [11,12] has generated a strong need to study the effects of these mutations on the development and functions of different neural cells. This evidence concerns the gene PTPA and early-onset autosomal dominant Alzheimer disease.